Improving HLA matching in living donor kidney transplantation using kidney paired exchange program

Transpl Immunol. 2020 Oct:62:101317. doi: 10.1016/j.trim.2020.101317. Epub 2020 Jul 4.

Abstract

Background: The inclusion of compatible pairs within kidney paired exchange programs has been described as a way to enhance these programs. Improved immunological matching for the recipient in compatible pair has been described to be a possible benefit.

Methods: The main purpose of our study was to determine if the introduction of compatible pairs in the Portuguese kidney paired exchange program would result in a better match for these patients, but also to assess if this strategy would increase the number of incompatible pairs with a possible match. We included 17 compatible pairs in kidney paired exchange pool of 35 pairs and performed an in-silico simulation determining HLA eplet mismatch load between the co-registered and matched pairs using HLA MatchMaker, version 3.0.

Results: Our study showed that the inclusion of fully HLA-A, -B, -DR mismatched compatible pairs within the national Portuguese KEP increased matched rate within ICP (0.71%) and improved HLA eplet matching within compatible pairs. 16 of 17 (94.12%) of the CP obtained one or more transplants possibilities and 13 (81.25%) would have been transplanted with significantly lower HLA class I and class II total and antibody-verified eplet mismatch load (83.9 ± 16.9 vs. 59.8 ± 12.2, P = .002 and 30.1 ± 5.5 vs. 21.2 ± 3.0, P = .003, respectively).

Conclusions: This strategy is a viable alternative for compatible pairs seeking a better matched kidney and Portuguese KEP program should allow them this possibility.

MeSH terms

  • Adult
  • Donor Selection / methods*
  • Female
  • Graft Rejection / prevention & control*
  • HLA Antigens / immunology*
  • Histocompatibility
  • Histocompatibility Testing / methods*
  • Humans
  • Isoantibodies / blood
  • Kidney Transplantation*
  • Living Donors*
  • Male
  • Portugal
  • Program Evaluation
  • Tissue and Organ Procurement

Substances

  • HLA Antigens
  • Isoantibodies